Long-Term Outcome and Health-Related Quality of Life of Elderly Patients After Meningioma Surgery.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
05 2019
Historique:
received: 14 09 2018
revised: 14 01 2019
accepted: 17 01 2019
pubmed: 9 2 2019
medline: 21 12 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

The incidence of meningiomas increases with increasing age. Because the median age for the diagnosis is 65 years, the patients' general health condition, comorbidities, and procedural risks will influence the postoperative functional outcomes. The aim of our study was to assess the long-term impairments of health-related quality of life (HRQOL) after meningioma resection in different age groups of elderly patients. We analyzed the HRQOL of 133 patients aged >54 years at surgery who had undergone surgical meningioma resection from 2004 to 2010. The median age was 67.3 ± 7.4 years. The average interval between surgery and questionnaire completion was 3.8 ± 2.5 years. Six different 5-year age groups were established. The patients completed the Medical Outcomes Study short-form 36-item questionnaire, and the results were compared with general population values. The Kruskal-Wallis test and Mann-Whitney U test were used for statistical analysis. We found significantly lower levels of physical function, vitality, social role functioning, mental health, and general health perception and significantly greater levels of pain between the older age groups (in particular, 75-79 years) and younger patients aged 55-59 years. The physical component summary showed a steadily and stepwise decline from younger to older patients. However, the most significant differences in HRQOL were not related to age but to comorbidities. Our findings suggest that Karnofsky performance scale and American Society of Anesthesiologists scores have a strong effect on long-term HRQOL, especially for older patients after meningioma resection. These data should be a substantial consideration in the preoperative decision-making process.

Identifiants

pubmed: 30735873
pii: S1878-8750(19)30258-X
doi: 10.1016/j.wneu.2019.01.158
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e697-e710

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Marco Timmer (M)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany. Electronic address: marco.timmer@uk-koeln.de.

Matthias Seibl-Leven (M)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Klaus Wittenstein (K)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Stefan Grau (S)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Pantelis Stavrinou (P)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Gabriele Röhn (G)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Boris Krischek (B)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Roland Goldbrunner (R)

Department of General Neurosurgery, Center for Neurosurgery, University Hospital Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH